A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint Blockade

Clinical trial NCT04807127 · UNKNOWN

Trial details

NCT number: NCT04807127
Sponsor: Universitaire Ziekenhuizen KU Leuven
Status: UNKNOWN
Study type: OBSERVATIONAL

Pneumonitis, Interstitial Immunotherapy Immune-related Adverse Events

Start date: 2020-02-01
Primary completion: 2025-01-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.